Biosensors Market Worth $22.68 Billion by 2020

DALLAS, TX -- According to a new market research report "Biosensors Market by Application (Point of Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Analysis & Forecast to 2020", published by MarketsandMarkets, the total biosensors market was valued at $11.39 Billion in 2013 and is expected to reach $22.68 Billion by 2020, at an estimated CAGR of 10.00% from 2014 to 2020.

The biosensors industry has witnessed significant technological developments over the last few years. Various studies have been carried out for incorporating the biosensors technology into various clinical and non-clinical applications ranging from medical, biodefense, environment monitoring, and food industry. The increase in demand of point-of-care diagnostics devices, growing prevalence of diabetes, aging population, and need to improve the current healthcare infrastructure are the key drivers propelling the growth of the market. This market in the report has been categorized by products, namely wearable biosensors and non-wearable biosensors.

MarketsandMarkets report covers the key application sectors of the biosensors market, which include Point of Care, home diagnostics, research labs, biodefense, environmental monitoring, and food industry. Among all the applications, the point of care diagnostics is expected to be the largest contributor to the overall biosensors market, holding 57% share.

The Biosensors Market for different geographic regions, including North America, Europe, Asia-Pacific, and the Rest of the World (RoW), has also been covered in the report. North America was the largest market for biosensors as of 2013. APAC has been the most promising market for biosensors over the forecast period and is expected to grow at the highest CAGR among all the regions.

Key Features:
•The wearable biosensors hold the maximum share of 80% of the total biosensors market as of 2013.
•The report profiles the promising major players with a SWOT analysis of the key players in the biosensors market. The market witnesses a series of new product launch announcements and partnerships across the value chain.
•The report also discusses the future of the global market with road-map, upcoming technologies, markets, and applications with respect to biosensors.

The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point of Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.

Browse 74 market data Tables and 82 Figures spread through 321Pages and in-depth TOC on "Biosensors Market" at http://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html

Early buyers will receive 10% customization on this report.

Inquire before buying at: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=798

Contact:

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
 

Suggested Articles

HP leads the pack, but Apple sees 36% surge in notebooks, desktops compared to a year ago

New York City residents moving upstate will give hundreds of towns extra tax revenue to invest in new streetlights with IoT sensors, NYPA foresees

With about one-fifth the revenues of Intel, Nvidia’s market capitalization exceeds Intel’s as Nvidia stock hits record high